TITLE

Letter: Thrombolytic therapy in haemolytic-uraemic syndrome

AUTHOR(S)
Ekert, E
PUB. DATE
November 1974
SOURCE
British Medical Journal;11/30/1974, Vol. 4 Issue 5943, p533
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64112380

 

Related Articles

  • HT-pre-eclampsiapostpartum haemolyticuraemic syndrome: good results can be achieved. Santos Nores, J.; Bravo L√≥pez, J. J.; Borrajo Prol, M. P.; Iglesias Forneiro, A. // Nefrologia;Oct2010, Vol. 30 Issue 5, p593 

    A letter to the editor are presented in relation to the diagnosis of haemolytic-uraemic syndrome (HUS) that infected a pregnant woman and the use of plasmapheresis (PP) and prednisone as its treatment.

  • Feasibility of acute thrombolytic therapy for stroke: Comments. Pandian, J. D. // Neurology India;Mar2004, Vol. 52 Issue 1, p126 

    Presents a letter to the editor in response to the article about the feasibility of thrombolytic therapy for stroke.

  • Authors' reply. Phillips, Bob; Tyerman, Kay; Whiteley, Simon M. // BMJ: British Medical Journal (International Edition);5/21/2005, Vol. 330 Issue 7501, p1209 

    Presents a letter to the editor from the authors of a study on the use of antibiotics in suspected haemolytic-uraemic syndrome by Phillips and others that appeared in the February 19, 2005 issue of the "British Medical Journal."

  • Antibiotics should not be used in Escherichia coli O157:H7 infection. Dundas, Stephanie; Todd, W. T. Andrew; Neill, Marguerite A.; Tarr, Phillip I. // BMJ: British Medical Journal (International Edition);5/21/2005, Vol. 330 Issue 7501, p1209 

    Presents a letter to the editor about a study on the use of antibiotics in suspected haemolytic-uraemic syndrome by Phillips and others that appeared in the February 19, 2005 issue of the "British Medical Journal."

  • Angioplasty's margin of superiority over thrombolysis for acute MI may be less than thought.  // Modern Medicine;May96, Vol. 64 Issue 5, p32 

    Reports on the use of thrombolytic therapy as a primary therapeutic strategy for patients with myocardial infarction. Results of the study `Global Use of Strategies to Opn Occluded Arteries in Acute Coronary Syndromes'; Comparison of thrombolytic therapy with angioplasty.

  • Postthrombolytic High-Risk Syndrome. Zatuchni, Jacob // Angiology;Aug1988, Vol. 39 Issue 8, p773 

    Presents a letter to the editor about post-thrombolytic high-risk syndrome.

  • CORRESPONDENCE. Birdwood, George; Banatvala, J.E.; Spencer, G.T.; Lewis, Barry; Sherris, John; Thornsberry, Clyde; Barry, Arthur L.; Owen, David A.; Tighe, J.R.; Taylor, J. Leahy; Patterson, James; Barnett, J.W. Brooke; Bird, H.C.; Jay, Barrie; Crawford, M.A.; Hassam, A.G.; Hunt, David; McRae, Colin // British Medical Journal;1/18/1975, Vol. 1 Issue 5950, p148 

    Presents several letters concerning medicine. Dangers of high-solute infant feeding; Degree of inhibition by linoleic acid of the response of human lymphocytes to antigen; Duration of action of practolol; Efficacy of thrombolytic therapy in hemolytic-uremic syndrome.

  • Splenic rupture: an additional complication of thrombolytic therapy. Summers, James Bradley // Critical Care Nurse;Oct2002, Vol. 22 Issue 5, p18 

    Presents a letter to the editor in response to the article "Reteplase: Nursing Implications for Catheter-Directed Thrombolytic Therapy for Peripheral Vascular Occlusions," about splenic rupture in thrombolytic therapy.

  • Differing procedures. Morris, Joann // Critical Care Nurse;Oct2002, Vol. 22 Issue 5, p19 

    Presents a letter to the editor in response to the article "Reteplase: Nursing Implications for Catheter-Directed Thrombolytic Therapy for Peripheral Vascular Occlusions," about differing procedures used in thrombolytic therapy.

  • Mitomycin: Haemolytic uraemic syndrome treated with eculizumab: case report.  // Reactions Weekly;Nov2013, Issue 1477, p23 

    An abstract of the article "Eculizumab and drug-induced haemolytic-uraemic syndrome," by S. Faguer and colleagues is presented.

Share

Other Topics